SMS Pharmaceuticals has informed that, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, read with the relevant circulars issued by BSE and National Stock Exchange of India and company's Code of Conduct for Prevention of Insider Trading of the Company, the Trading Window for dealing in shares of the Company for all designated persons and their immediate relatives shall remain closed from 01st April, 2025 till 48 hours after the declaration of financial results for the fourth quarter and year ended 31st March, 2025. The date of Board Meeting for the consideration of financial results of the Company for the fourth quarter and year ended 31st March, 2025 shall be intimated in due course of time.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1839.85 |
| Dr. Reddys Lab | 1293.00 |
| Cipla | 1340.75 |
| Zydus Lifesciences | 940.00 |
| Lupin | 2344.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: